DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Ajanta Pharma Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3 hrs ago·30 Jul 2026, 12:10 pm

Ajanta Pharma

Ajanta Pharma has informed stock exchanges that it will hold an institutional investor meet and conference call. This event is a standard corporate procedure where the company management presents its business strategy, financial performance, and future outlook directly to analysts and investors.

For investors, such meetings are significant as they provide clarity on the company's growth plans and operational health. Positive guidance or detailed insights from management can help investors better understand the firm's competitive positioning and long-term potential.

Investors should watch for updates on the company's product pipeline, export market performance, and any strategic initiatives discussed during the interaction to gauge the stock's future trajectory.